Reference Source

Federal controlled substance schedule (I-V) by drug, with DEA code number

Every substance named in the federal drug schedules at 21 CFR 1308.11-1308.15, with the schedule it sits in, its DEA Controlled Substances Code Number, the class it is listed under, and the exact paragraph of the regulation the entry comes from. One record is one substance at one paragraph, quoted from the regulation itself. A drug can sit in more than one schedule at the same time, and the difference is usually the preparation rather than the drug: codeine is Schedule II on its own, Schedule III in a limited-strength compound, and Schedule V at not more than 200 milligrams per 100 millilitres. Each of those is a separate record, so the answer is not silently collapsed into whichever listing came first. Marijuana is split the same way: Schedule I as a plant, and Schedule III in an FDA-approved product or when subject to a state medical marijuana licence. Substances placed in Schedule I on an emergency temporary basis carry the date that placement runs until. Two limits are worth knowing: the anabolic steroids in 1308.13(f) share a single code number for the whole class, so individual steroids are published with no code rather than an invented one, and a few entries print XXXX where a code would go. Answers what schedule a given drug is in, whether marijuana is Schedule I or III, what the DEA code number for a substance is, and when a temporary listing expires.

Records591
Sources1
Verified
Review by
LicenceFederal regulatory text (21 CFR), not copyrightable

The data

SubstanceScheduleListed underDEA code numberTemporary listing expiresCFR citationOnly when
1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968)Schedule ITemporary listing of substances subject to emergency scheduling9097Aug. 27, 202821 CFR 1308.11(h)(92)
1-[1-(2-thienyl)cyclohexyl]pyrrolidineSchedule IHallucinogenic substances747321 CFR 1308.11(d)(35)
1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone)Schedule IHallucinogenic substances755221 CFR 1308.11(d)(105)
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB)Schedule IHallucinogenic substances754921 CFR 1308.11(d)(101)
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone)Schedule IHallucinogenic substances754721 CFR 1308.11(d)(80)
1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB)Schedule IHallucinogenic substances754121 CFR 1308.11(d)(62)
1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP)Schedule IHallucinogenic substances754221 CFR 1308.11(d)(64)
1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78)Schedule IHallucinogenic substances708921 CFR 1308.11(d)(83)
(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144)Schedule IHallucinogenic substances701421 CFR 1308.11(d)(93)
1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA)Schedule IHallucinogenic substances124521 CFR 1308.11(d)(88)
[1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11)Schedule IHallucinogenic substances701121 CFR 1308.11(d)(49)
1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201)Schedule IHallucinogenic substances720121 CFR 1308.11(d)(108)
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25)Schedule IHallucinogenic substances708321 CFR 1308.11(d)(92)
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA)Schedule IHallucinogenic substances708521 CFR 1308.11(d)(85)
1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(3)
1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(4)
1-androstenedione (5α-androst-1-en-3,17-dione)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(7)
1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone)Schedule IHallucinogenic substances125821 CFR 1308.11(d)(67)
1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678)Schedule IHallucinogenic substances711821 CFR 1308.11(d)(107)
1-phenylcyclohexylamineSchedule IIImmediate precursors746021 CFR 1308.12(g)(2)(i)
1-piperidinocyclohexanecarbonitrile (PCC)Schedule IIImmediate precursors860321 CFR 1308.12(g)(2)(ii)
2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene)Schedule ITemporary listing of substances subject to emergency scheduling9770Oct. 15, 202721 CFR 1308.11(h)(79)
2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene)Schedule IOpiates976521 CFR 1308.11(b)(42)
2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene)Schedule ITemporary listing of substances subject to emergency scheduling9767Oct. 15, 202721 CFR 1308.11(h)(81)
2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene)Schedule ITemporary listing of substances subject to emergency scheduling9768Oct. 15, 202721 CFR 1308.11(h)(82)
2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene)Schedule ITemporary listing of substances subject to emergency scheduling9771Oct. 15, 202721 CFR 1308.11(h)(84)
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)Schedule IHallucinogenic substances750921 CFR 1308.11(d)(38)
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)Schedule IHallucinogenic substances750821 CFR 1308.11(d)(39)
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)Schedule IHallucinogenic substances752421 CFR 1308.11(d)(46)
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N)Schedule IHallucinogenic substances752121 CFR 1308.11(d)(45)
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)Schedule IHallucinogenic substances751721 CFR 1308.11(d)(44)
2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3′,4′-methylenedioxynitazene)Schedule ITemporary listing of substances subject to emergency scheduling9766Oct. 15, 202721 CFR 1308.11(h)(80)
2α,3α-epithio-17α-methyl-5α-androstan-17β-olSchedule IIIAnabolic steroids21 CFR 1308.13(f)(29)
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe)Schedule IHallucinogenic substances753621 CFR 1308.11(d)(57)
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)Schedule IHallucinogenic substances751921 CFR 1308.11(d)(40)
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe)Schedule IHallucinogenic substances753721 CFR 1308.11(d)(56)
2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne)Schedule IOpiates975821 CFR 1308.11(b)(78)
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)Schedule IHallucinogenic substances738521 CFR 1308.11(d)(42)
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)Schedule IHallucinogenic substances751821 CFR 1308.11(d)(41)
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe)Schedule IHallucinogenic substances753821 CFR 1308.11(d)(55)
2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene)Schedule ITemporary listing of substances subject to emergency scheduling9772Oct. 15, 202721 CFR 1308.11(h)(85)
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4)Schedule IHallucinogenic substances753221 CFR 1308.11(d)(43)
2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne)Schedule IOpiates976221 CFR 1308.11(b)(79)
2,5-dimethoxy-4-ethylamphet-amineSchedule IHallucinogenic substances739921 CFR 1308.11(d)(5)
2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)Schedule IHallucinogenic substances734821 CFR 1308.11(d)(6)
2,5-dimethoxyamphetamineSchedule IHallucinogenic substances739621 CFR 1308.11(d)(4)
2′,5′-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)Schedule IOpiates986121 CFR 1308.11(b)(37)
2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-oneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(27)
2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol)Schedule IVNarcotic drugs975221 CFR 1308.14(b)(3)
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE)Schedule IHallucinogenic substances728621 CFR 1308.11(d)(100)
2′-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2′-fluoro 2-fluorofentanyl)Schedule IOpiates985521 CFR 1308.11(b)(48)
2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK)Schedule ITemporary listing of substances subject to emergency scheduling7284May 22, 202821 CFR 1308.11(h)(87)
2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one)Schedule IOpiates966421 CFR 1308.11(b)(64)
2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone)Schedule IHallucinogenic substances125921 CFR 1308.11(d)(104)
2-(methylamino)-1-phenylpentan-1-one (pentedrone)Schedule IHallucinogenic substances124621 CFR 1308.11(d)(63)
3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine)Schedule ITemporary listing of substances subject to emergency scheduling9094Aug. 27, 202821 CFR 1308.11(h)(94)
3,4,5-trimethoxy amphetamineSchedule IHallucinogenic substances739021 CFR 1308.11(d)(14)
3,4-methylenedioxy amphetamineSchedule IHallucinogenic substances740021 CFR 1308.11(d)(10)
3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEASchedule IHallucinogenic substances740421 CFR 1308.11(d)(12)
3,4-Methylenedioxy-N-methylcathinone (Methylone)Schedule IHallucinogenic substances754021 CFR 1308.11(d)(47)
3,4-methylenedioxymethamphetamine (MDMA)Schedule IHallucinogenic substances740521 CFR 1308.11(d)(11)
3,4-methylenedioxypyrovalerone (MDPV)Schedule IHallucinogenic substances753521 CFR 1308.11(d)(37)
3β,17β-dihydroxy-5α-androstaneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(25)
3α,17β-dihydroxy-5α-androstaneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(26)
3-fluoro-N-methylcathinone (3-FMC)Schedule IHallucinogenic substances123321 CFR 1308.11(d)(66)
3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide)Schedule IOpiates986021 CFR 1308.11(b)(50)
3β-hydroxy-estra-4,9,11-trien-17-oneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(42)
3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP)Schedule IHallucinogenic substances745721 CFR 1308.11(d)(109)
3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)Schedule IOpiates981321 CFR 1308.11(b)(65)
3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide)Schedule IOpiates983321 CFR 1308.11(b)(66)
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)Schedule IStimulants159521 CFR 1308.11(f)(5)
4-androstenediol (3β,17β-dihydroxy-androst-4-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(5)
4-androstenedione (androst-4-en-3,17-dione)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(8)
4-anilino-N-phenethylpiperidine (ANPP)Schedule IIImmediate precursors833321 CFR 1308.12(g)(3)(i)
4-bromo-2,5-dimethoxy-amphetamineSchedule IHallucinogenic substances739121 CFR 1308.11(d)(2)
4-Bromo-2,5-dimethoxyphenethylamineSchedule IHallucinogenic substances739221 CFR 1308.11(d)(3)
4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-oneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(18)
4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dioneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(19)
4-chloro-17α-methyl-androst-4-ene-3β,17β-diolSchedule IIIAnabolic steroids21 CFR 1308.13(f)(17)
4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diolSchedule IIIAnabolic steroids21 CFR 1308.13(f)(16)
4′-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-α-PVP; 4′-chloro-α-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one)Schedule IHallucinogenic substances744321 CFR 1308.11(d)(99)
4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one)Schedule IHallucinogenic substances123921 CFR 1308.11(d)(106)
4-dihydrotestosterone (17β-hydroxy-androstan-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(23)
4-fluoro-N-methylcathinone (4-FMC; flephedrone)Schedule IHallucinogenic substances123821 CFR 1308.11(d)(65)
4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine)Schedule IStimulants147621 CFR 1308.11(f)(8)
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl)Schedule IOpiates982421 CFR 1308.11(b)(47)
4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(38)
4-hydroxy-androst-4-ene-3,17-dioneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(39)
4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(43)
4-methoxyamphetamineSchedule IHallucinogenic substances741121 CFR 1308.11(d)(7)
4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: α-PiHP; alpha-PiHP)Schedule IHallucinogenic substances755121 CFR 1308.11(d)(103)
4-methyl-2,5-dimethoxy-amphetamineSchedule IHallucinogenic substances739521 CFR 1308.11(d)(9)
4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide)Schedule IOpiates981921 CFR 1308.11(b)(63)
4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one)Schedule IHallucinogenic substances724521 CFR 1308.11(d)(96)
4′-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4′-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one)Schedule IHallucinogenic substances744621 CFR 1308.11(d)(97)
4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP)Schedule IHallucinogenic substances749821 CFR 1308.11(d)(60)
4-methyl-N-ethylcathinone (4-MEC)Schedule IHallucinogenic substances124921 CFR 1308.11(d)(59)
4-methylmethcathinone (Mephedrone)Schedule IHallucinogenic substances124821 CFR 1308.11(d)(36)
5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018)Schedule ITemporary listing of substances subject to emergency scheduling9096Aug. 27, 202821 CFR 1308.11(h)(93)
5α-androstan-3,6,17-trioneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(2)
5α-androstan-3,17-dioneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(1)
5-androstenediol (3β,17β-dihydroxy-androst-5-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(6)
5-androstenedione (androst-5-en-3,17-dione)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(9)
5-methoxy-3,4-methylenedioxy-amphetamineSchedule IHallucinogenic substances740121 CFR 1308.11(d)(8)
5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT)Schedule IHallucinogenic substances743921 CFR 1308.11(d)(20)
5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMTSchedule IHallucinogenic substances743121 CFR 1308.11(d)(15)
5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne)Schedule IOpiates976321 CFR 1308.11(b)(80)
5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151)Schedule IHallucinogenic substances709321 CFR 1308.11(d)(116)
6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC)Schedule IHallucinogenic substances722021 CFR 1308.11(d)(115)
6-bromo-androsta-1,4-diene-3,17-dioneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(13)
6-bromo-androstan-3,17-dioneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(14)
6α-methyl-androst-4-ene-3,17-dioneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(53)
8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890)Schedule ITemporary listing of substances subject to emergency scheduling9093Aug. 27, 202821 CFR 1308.11(h)(95)
8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam)Schedule ITemporary listing of substances subject to emergency scheduling2778Mar. 16, 202821 CFR 1308.11(h)(86)
13β-ethyl-17β-hydroxygon-4-en-3-oneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(31)
17β-hydroxy-androstano[2,3-d]isoxazoleSchedule IIIAnabolic steroids21 CFR 1308.13(f)(40)
17β-hydroxy-androstano[3,2-c]isoxazoleSchedule IIIAnabolic steroids21 CFR 1308.13(f)(41)
17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) (a.k.a. “17-α-methyl-1-testosterone”)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(60)
17α-methyl-3β,17β-dihydroxy-5α-androstaneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(55)
17α-methyl-3α,17β-dihydroxy-5α-androstaneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(56)
17α-methyl-3β,17β-dihydroxyandrost-4-eneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(57)
17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(58)
17α-methyl-5α-androstan-17β-olSchedule IIIAnabolic steroids21 CFR 1308.13(f)(51)
17α-methyl-androst-2-ene-3,17β-diolSchedule IIIAnabolic steroids21 CFR 1308.13(f)(54)
17α-methyl-androsta-1,4-diene-3,17β-diolSchedule IIIAnabolic steroids21 CFR 1308.13(f)(50)
17α-methyl-androstan-3-hydroxyimine-17β-olSchedule IIIAnabolic steroids21 CFR 1308.13(f)(52)
18a-homo-3-hydroxy-estra-2,5(10)-dien-17-oneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(37)
19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(69)
19-nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(65)
19-nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(66)
19-nor-4-androstenedione (estr-4-en-3,17-dione)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(70)
19-nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(67)
19-nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(68)
19-nor-5-androstenedione (estr-5-en-3,17-dione)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(71)
[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)Schedule IHallucinogenic substances702421 CFR 1308.11(d)(71)
Δ1-dihydrotestosterone (a.k.a. “1-testosterone”) (17β-hydroxy-5α-androst-1-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(24)
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144)Schedule IHallucinogenic substances714421 CFR 1308.11(d)(48)
[3,2-c]furazan-5α-androstan-17β-olSchedule IIIAnabolic steroids21 CFR 1308.13(f)(36)
[3,2-c]pyrazole-androst-4-en-17β-olSchedule IIIAnabolic steroids21 CFR 1308.13(f)(80)
AcetorphineSchedule IOpium derivatives931921 CFR 1308.11(c)(1)
Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)Schedule IOpiates981521 CFR 1308.11(b)(1)
Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)Schedule IOpiates982121 CFR 1308.11(b)(3)
AcetyldihydrocodeineSchedule IOpium derivatives905121 CFR 1308.11(c)(2)
AcetylmethadolSchedule IOpiates960121 CFR 1308.11(b)(2)
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl)Schedule IOpiates981121 CFR 1308.11(b)(4)
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)Schedule IOpiates955121 CFR 1308.11(b)(5)
AlfaxaloneSchedule IVDepressants273121 CFR 1308.14(c)(1)
AlfentanilSchedule IIOpiates973721 CFR 1308.12(c)(1)
AllylprodineSchedule IOpiates960221 CFR 1308.11(b)(6)
Alpha-ethyltryptamineSchedule IHallucinogenic substances724921 CFR 1308.11(d)(1)
alpha′-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)Schedule IOpiates986421 CFR 1308.11(b)(10)
alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine)Schedule IOpiates981421 CFR 1308.11(b)(11)
alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)Schedule IOpiates983221 CFR 1308.11(b)(12)
Alpha-methyltryptamine (other name: AMT)Schedule IHallucinogenic substances743221 CFR 1308.11(d)(16)
alpha-pyrrolidinobutiophenone (α-PBP)Schedule IHallucinogenic substances754621 CFR 1308.11(d)(68)
alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one)Schedule IHallucinogenic substances754821 CFR 1308.11(d)(98)
alpha-Pyrrolidinohexanophenone (Other names: α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one)Schedule IHallucinogenic substances754421 CFR 1308.11(d)(95)
alpha-pyrrolidinopentiophenone (α-PVP)Schedule IHallucinogenic substances754521 CFR 1308.11(d)(61)
Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM)Schedule IOpiates960321 CFR 1308.11(b)(7)
AlphameprodineSchedule IOpiates960421 CFR 1308.11(b)(8)
AlphamethadolSchedule IOpiates960521 CFR 1308.11(b)(9)
AlphaprodineSchedule IIOpiates901021 CFR 1308.12(c)(2)
AlprazolamSchedule IVDepressants288221 CFR 1308.14(c)(2)
Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)Schedule IStimulants121921 CFR 1308.11(f)(1)
Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine)Schedule IStimulants158521 CFR 1308.11(f)(2)
AmobarbitalSchedule IIDepressants212521 CFR 1308.12(e)(1)
AmobarbitalSchedule IIIDepressants212621 CFR 1308.13(c)(1)(i)Any compound, mixture or preparation containing
AmobarbitalSchedule IIIDepressants212621 CFR 1308.13(c)(2)(i)Any suppository dosage form containing
Amphetamine, its salts, optical isomers, and salts of its optical isomersSchedule IIStimulants110021 CFR 1308.12(d)(1)
AnileridineSchedule IIOpiates902021 CFR 1308.12(c)(3)
Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic ActSchedule IIIDepressants201221 CFR 1308.13(c)(6)
Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opiumSchedule IISubstances, vegetable origin or chemical synthesis21 CFR 1308.12(b)(2)
Any substance which contains any quantity of a derivative of barbituric acid or any salt thereofSchedule IIIDepressants210021 CFR 1308.13(c)(3)
BarbitalSchedule IVDepressants214521 CFR 1308.14(c)(3)
BenzethidineSchedule IOpiates960621 CFR 1308.11(b)(13)
BenzphetamineSchedule IIIStimulants122821 CFR 1308.13(b)(2)
BenzylmorphineSchedule IOpium derivatives905221 CFR 1308.11(c)(3)
beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide)Schedule IOpiates983121 CFR 1308.11(b)(16)
beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide)Schedule IOpiates983021 CFR 1308.11(b)(15)
beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide)Schedule IOpiates983621 CFR 1308.11(b)(17)
beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl)Schedule IOpiates985621 CFR 1308.11(b)(20)
beta-methylacetyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide)Schedule IOpiates986821 CFR 1308.11(b)(21)
beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as β′-phenyl fentanyl; 3-phenylpropanoyl fentanyl)Schedule IOpiates984221 CFR 1308.11(b)(22)
BetacetylmethadolSchedule IOpiates960721 CFR 1308.11(b)(14)
BetameprodineSchedule IOpiates960821 CFR 1308.11(b)(18)
BetamethadolSchedule IOpiates960921 CFR 1308.11(b)(19)
BetaprodineSchedule IOpiates961121 CFR 1308.11(b)(23)
BezitramideSchedule IIOpiates980021 CFR 1308.12(c)(4)
bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(10)
boldenone (17β-hydroxyandrost-1,4-diene-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(11)
boldione (androsta-1,4-diene-3,17-dione)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(12)
BrexanoloneSchedule IVDepressants240021 CFR 1308.14(c)(4)
Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact) (including its salts)Schedule VDepressants271021 CFR 1308.15(e)(1)
BromazepamSchedule IVDepressants274821 CFR 1308.14(c)(5)
brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one)Schedule IOpiates909821 CFR 1308.11(b)(24)
BufotenineSchedule IHallucinogenic substances743321 CFR 1308.11(d)(17)
Bulk dextropropoxyphene (non-dosage forms)Schedule IIOpiates927321 CFR 1308.12(c)(5)
BuprenorphineSchedule IIINarcotic drugs906421 CFR 1308.13(e)(2)(i)
Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine)Schedule IOpiates975121 CFR 1308.11(b)(25)
Butorphanol (including its optical isomers)Schedule IVOther substances972021 CFR 1308.14(g)(2)
Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide)Schedule IOpiates982221 CFR 1308.11(b)(26)
calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(15)
CamazepamSchedule IVDepressants274921 CFR 1308.14(c)(6)
Cannabimimetic agentsSchedule ICannabimimetic agents700021 CFR 1308.11(g)(1)
CarfentanilSchedule IIOpiates974321 CFR 1308.12(c)(6)
CarisoprodolSchedule IVDepressants819221 CFR 1308.14(c)(7)
Cathine ((+)-norpseudoephedrine)Schedule IVStimulants123021 CFR 1308.14(f)(1)
CathinoneSchedule IStimulants123521 CFR 1308.11(f)(4)
Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester)Schedule VDepressants272021 CFR 1308.15(e)(2)
Chloral betaineSchedule IVDepressants246021 CFR 1308.14(c)(8)
Chloral hydrateSchedule IVDepressants246521 CFR 1308.14(c)(9)
ChlordiazepoxideSchedule IVDepressants274421 CFR 1308.14(c)(10)
ChlorhexadolSchedule IIIDepressants251021 CFR 1308.13(c)(4)
ChlorphentermineSchedule IIIStimulants164521 CFR 1308.13(b)(3)
CipepofolSchedule IVDepressants213921 CFR 1308.14(c)(11)
(±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine)Schedule IStimulants159021 CFR 1308.11(f)(12)
ClobazamSchedule IVDepressants275121 CFR 1308.14(c)(12)
ClonazepamSchedule IVDepressants273721 CFR 1308.14(c)(13)
Clonazolam (Other name: 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)Schedule IDepressants278621 CFR 1308.11(e)(1)
ClonitazeneSchedule IOpiates961221 CFR 1308.11(b)(27)
ClorazepateSchedule IVDepressants276821 CFR 1308.14(c)(14)
ClortermineSchedule IIIStimulants164721 CFR 1308.13(b)(4)
clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(20)
ClotiazepamSchedule IVDepressants275221 CFR 1308.14(c)(15)
CloxazolamSchedule IVDepressants275321 CFR 1308.14(c)(16)
Coca leavesSchedule IISubstances, vegetable origin or chemical synthesis904021 CFR 1308.12(b)(4)
cocaineSchedule IISubstances, vegetable origin or chemical synthesis904121 CFR 1308.12(b)(4)
CodeineSchedule IISubstances, vegetable origin or chemical synthesis905021 CFR 1308.12(b)(1)(i)
codeineSchedule IIINarcotic drugs980321 CFR 1308.13(e)(1)(i)Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium
codeineSchedule IIINarcotic drugs980421 CFR 1308.13(e)(1)(ii)Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
codeineSchedule VNarcotic drugs containing non-narcotic active medicinal ingredients21 CFR 1308.15(c)(1)Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams
Codeine methylbromideSchedule IOpium derivatives907021 CFR 1308.11(c)(4)
Codeine-N-OxideSchedule IOpium derivatives905321 CFR 1308.11(c)(5)
Concentrate of poppy strawSchedule IISubstances, vegetable origin or chemical synthesis967021 CFR 1308.12(b)(5)
Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)Schedule IOpiates984421 CFR 1308.11(b)(28)
Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide)Schedule IOpiates984721 CFR 1308.11(b)(29)
Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide)Schedule IOpiates984521 CFR 1308.11(b)(30)
CyprenorphineSchedule IOpium derivatives905421 CFR 1308.11(c)(6)
DaridorexantSchedule IVDepressants241021 CFR 1308.14(c)(17)
dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-methyl-androst-1,4-dien-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(21)
DelorazepamSchedule IVDepressants275421 CFR 1308.14(c)(18)
DesomorphineSchedule IOpium derivatives905521 CFR 1308.11(c)(7)
desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol) (a.k.a. “madol”)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(22)
DextromoramideSchedule IOpiates961321 CFR 1308.11(b)(31)
Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane)Schedule IVNarcotic drugs927821 CFR 1308.14(b)(2)
DiampromideSchedule IOpiates961521 CFR 1308.11(b)(32)
DiazepamSchedule IVDepressants276521 CFR 1308.14(c)(19)
DichloralphenazoneSchedule IVDepressants246721 CFR 1308.14(c)(20)
Diclazepam (Other name: 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)Schedule IDepressants278921 CFR 1308.11(e)(2)
DiethylpropionSchedule IVStimulants161021 CFR 1308.14(f)(2)
DiethylthiambuteneSchedule IOpiates961621 CFR 1308.11(b)(33)
DiethyltryptamineSchedule IHallucinogenic substances743421 CFR 1308.11(d)(18)
DifenoxinSchedule IOpiates916821 CFR 1308.11(b)(34)
difenoxinSchedule VNarcotic drugs containing non-narcotic active medicinal ingredients21 CFR 1308.15(c)(6)Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit
DihydrocodeineSchedule IIOpiates912021 CFR 1308.12(c)(7)
dihydrocodeineSchedule IIINarcotic drugs980721 CFR 1308.13(e)(1)(iii)Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts
dihydrocodeineSchedule VNarcotic drugs containing non-narcotic active medicinal ingredients21 CFR 1308.15(c)(2)Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams
DihydroetorphineSchedule IISubstances, vegetable origin or chemical synthesis933421 CFR 1308.12(b)(1)(ii)
DihydromorphineSchedule IOpium derivatives914521 CFR 1308.11(c)(8)
DimenoxadolSchedule IOpiates961721 CFR 1308.11(b)(35)
DimepheptanolSchedule IOpiates961821 CFR 1308.11(b)(36)
DimethylthiambuteneSchedule IOpiates961921 CFR 1308.11(b)(38)
DimethyltryptamineSchedule IHallucinogenic substances743521 CFR 1308.11(d)(19)
Dioxaphetyl butyrateSchedule IOpiates962121 CFR 1308.11(b)(39)
DiphenoxylateSchedule IIOpiates917021 CFR 1308.12(c)(8)
diphenoxylateSchedule VNarcotic drugs containing non-narcotic active medicinal ingredients21 CFR 1308.15(c)(4)Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit
DipipanoneSchedule IOpiates962221 CFR 1308.11(b)(40)
Dronabinol [(-)-delta-9-trans tetrahydrocannabinol]Schedule IIHallucinogenic substances736521 CFR 1308.12(f)(2)in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration
Dronabinol (synthetic)Schedule IIIHallucinogenic substances736921 CFR 1308.13(g)(1)in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product
drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(28)
DrotebanolSchedule IOpium derivatives933521 CFR 1308.11(c)(9)
ecgonineSchedule IISubstances, vegetable origin or chemical synthesis918021 CFR 1308.12(b)(4)
Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomersSchedule IVOther substances972521 CFR 1308.14(g)(3)
EmbutramideSchedule IIIDepressants202021 CFR 1308.13(c)(5)
EstazolamSchedule IVDepressants275621 CFR 1308.14(c)(21)
estra-4,9,11-triene-3,17-dioneSchedule IIIAnabolic steroids21 CFR 1308.13(f)(30)
EthchlorvynolSchedule IVDepressants254021 CFR 1308.14(c)(22)
EthinamateSchedule IVDepressants254521 CFR 1308.14(c)(23)
ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (other name: 5F-EDMB-PINACA)Schedule IHallucinogenic substances703621 CFR 1308.11(d)(89)
Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 5F-EDMB-PICA; 5F-EDMB-2201)Schedule IHallucinogenic substances709421 CFR 1308.11(d)(113)
Ethyl loflazepateSchedule IVDepressants275821 CFR 1308.14(c)(24)
Ethylamine analog of phencyclidineSchedule IHallucinogenic substances745521 CFR 1308.11(d)(32)
ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(32)
EthylmethylthiambuteneSchedule IOpiates962321 CFR 1308.11(b)(41)
EthylmorphineSchedule IISubstances, vegetable origin or chemical synthesis919021 CFR 1308.12(b)(1)(iii)
ethylmorphineSchedule IIINarcotic drugs980821 CFR 1308.13(e)(1)(iv)Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
ethylmorphineSchedule VNarcotic drugs containing non-narcotic active medicinal ingredients21 CFR 1308.15(c)(3)Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams
Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)Schedule IStimulants172721 CFR 1308.11(f)(6)
Etizolam (Other name: 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)Schedule IDepressants278021 CFR 1308.11(e)(3)
EtonitazeneSchedule IOpiates962421 CFR 1308.11(b)(43)
Etorphine (except hydrochloride salt)Schedule IOpium derivatives905621 CFR 1308.11(c)(10)
Etorphine hydrochlorideSchedule IISubstances, vegetable origin or chemical synthesis905921 CFR 1308.12(b)(1)(iv)
EtoxeridineSchedule IOpiates962521 CFR 1308.11(b)(44)
Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]Schedule VDepressants277921 CFR 1308.15(e)(3)
FencamfaminSchedule IVStimulants176021 CFR 1308.14(f)(3)
FenethyllineSchedule IStimulants150321 CFR 1308.11(f)(7)
FenproporexSchedule IVStimulants157521 CFR 1308.14(f)(4)
FentanylSchedule IIOpiates980121 CFR 1308.12(c)(9)
Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate)Schedule IOpiates985121 CFR 1308.11(b)(45)
Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethersSchedule ITemporary listing of substances subject to emergency scheduling985021 CFR 1308.11(h)(30)
Flualprazolam (Other name: 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)Schedule IDepressants278521 CFR 1308.11(e)(4)
Flubromazolam (Other name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)Schedule IDepressants278821 CFR 1308.11(e)(5)
FludiazepamSchedule IVDepressants275921 CFR 1308.14(c)(25)
Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)Schedule IOpiates975621 CFR 1308.11(b)(46)
FlunitrazepamSchedule IVDepressants276321 CFR 1308.14(c)(26)
fluoxymesterone (9-fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(33)
FlurazepamSchedule IVDepressants276721 CFR 1308.14(c)(27)
formebolone (2-formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(34)
FospropofolSchedule IVDepressants213821 CFR 1308.14(c)(28)
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)Schedule IOpiates983421 CFR 1308.11(b)(49)
furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]furazan)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(35)
FurethidineSchedule IOpiates962621 CFR 1308.11(b)(51)
gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate)Schedule IDepressants201021 CFR 1308.11(e)(6)
Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one)Schedule VDepressants240121 CFR 1308.15(e)(4)
GlutethimideSchedule IIDepressants255021 CFR 1308.12(e)(2)
Granulated opiumSchedule IISubstances, vegetable origin or chemical synthesis964021 CFR 1308.12(b)(1)(v)
HalazepamSchedule IVDepressants276221 CFR 1308.14(c)(29)
HaloxazolamSchedule IVDepressants277121 CFR 1308.14(c)(30)
HeroinSchedule IOpium derivatives920021 CFR 1308.11(c)(11)
HydrocodoneSchedule IISubstances, vegetable origin or chemical synthesis919321 CFR 1308.12(b)(1)(vi)
HydromorphinolSchedule IOpium derivatives930121 CFR 1308.11(c)(12)
HydromorphoneSchedule IISubstances, vegetable origin or chemical synthesis915021 CFR 1308.12(b)(1)(vii)
HydroxypethidineSchedule IOpiates962721 CFR 1308.11(b)(52)
IbogaineSchedule IHallucinogenic substances726021 CFR 1308.11(d)(21)
Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide)Schedule IOpiates982721 CFR 1308.11(b)(53)
IsomethadoneSchedule IIOpiates922621 CFR 1308.12(c)(10)
Isotonitazene (N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)Schedule IOpiates961421 CFR 1308.11(b)(54)
Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)Schedule IOpiates986221 CFR 1308.11(b)(55)
Ketamine, its salts, isomers, and salts of isomersSchedule IIIDepressants728521 CFR 1308.13(c)(7)
KetazolamSchedule IVDepressants277221 CFR 1308.14(c)(31)
KetobemidoneSchedule IOpiates962821 CFR 1308.11(b)(56)
Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide]Schedule VDepressants274621 CFR 1308.15(e)(5)
Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide]Schedule VDepressants279021 CFR 1308.15(e)(6)
LemborexantSchedule IVDepressants224521 CFR 1308.14(c)(32)
Levo-alphacetylmethadolSchedule IIOpiates964821 CFR 1308.12(c)(11)
LevomethorphanSchedule IIOpiates921021 CFR 1308.12(c)(12)
LevomoramideSchedule IOpiates962921 CFR 1308.11(b)(57)
LevophenacylmorphanSchedule IOpiates963121 CFR 1308.11(b)(58)
LevorphanolSchedule IIOpiates922021 CFR 1308.12(c)(13)
Lisdexamfetamine, its salts, isomers, and salts of its isomersSchedule IIStimulants120521 CFR 1308.12(d)(5)
LoprazolamSchedule IVDepressants277321 CFR 1308.14(c)(33)
LorazepamSchedule IVDepressants288521 CFR 1308.14(c)(34)
LorcaserinSchedule IVLorcaserin162521 CFR 1308.14(e)(1)
LormetazepamSchedule IVDepressants277421 CFR 1308.14(c)(35)
Lysergic acidSchedule IIIDepressants730021 CFR 1308.13(c)(8)
Lysergic acid amideSchedule IIIDepressants731021 CFR 1308.13(c)(9)
Lysergic acid diethylamideSchedule IHallucinogenic substances731521 CFR 1308.11(d)(22)
MarihuanaSchedule IHallucinogenic substances736021 CFR 1308.11(d)(23)
Marihuana ExtractSchedule IHallucinogenic substances735021 CFR 1308.11(d)(58)
MarijuanaSchedule IIIHallucinogenic substances21 CFR 1308.13(g)(2)in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license
Marijuana extractSchedule IIIHallucinogenic substances21 CFR 1308.13(g)(3)in a U.S. Food and Drug Administration approved product or subject to a state medical marijuana license
MazindolSchedule IVStimulants160521 CFR 1308.14(f)(5)
MebutamateSchedule IVDepressants280021 CFR 1308.14(c)(36)
MecloqualoneSchedule IDepressants257221 CFR 1308.11(e)(7)
MedazepamSchedule IVDepressants283621 CFR 1308.14(c)(37)
MefenorexSchedule IVStimulants158021 CFR 1308.14(f)(6)
MeprobamateSchedule IVDepressants282021 CFR 1308.14(c)(388)
MescalineSchedule IHallucinogenic substances738121 CFR 1308.11(d)(24)
Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)Schedule IStimulants122721 CFR 1308.11(f)(9)
mestanolone (17α-methyl-17β-hydroxy-5α-androstan-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(44)
mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(45)
meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide)Schedule IOpiates985721 CFR 1308.11(b)(59)
meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide)Schedule IOpiates987121 CFR 1308.11(b)(60)
meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)Schedule IOpiates985821 CFR 1308.11(b)(61)
MetazocineSchedule IIOpiates924021 CFR 1308.12(c)(14)
MethadoneSchedule IIOpiates925021 CFR 1308.12(c)(15)
Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butaneSchedule IIOpiates925421 CFR 1308.12(c)(16)
Methamphetamine, its salts, isomers, and salts of its isomersSchedule IIStimulants110521 CFR 1308.12(d)(2)
methandienone (17α-methyl-17β-hydroxyandrost-1,4-dien-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(46)
methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-ene)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(47)
MethaqualoneSchedule IDepressants256521 CFR 1308.11(e)(8)
methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one or 2α,17α-dimethyl-17β-hydroxy-5α-androstan-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(48)
Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomersSchedule IStimulants123721 CFR 1308.11(f)(10)
methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(49)
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine)Schedule IStimulants147821 CFR 1308.11(f)(11)
MethohexitalSchedule IVDepressants226421 CFR 1308.14(c)(39)
Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)Schedule IOpiates982521 CFR 1308.11(b)(62)
methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-FUBINACA)Schedule IHallucinogenic substances702021 CFR 1308.11(d)(78)
methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA)Schedule IHallucinogenic substances702121 CFR 1308.11(d)(79)
Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate (other name: MMB-FUBICA)Schedule IHallucinogenic substances709521 CFR 1308.11(d)(114)
methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA)Schedule IHallucinogenic substances704321 CFR 1308.11(d)(87)
Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA)Schedule IHallucinogenic substances709121 CFR 1308.11(d)(111)
methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F-ADB; 5F-MDMB-PINACA)Schedule IHallucinogenic substances703421 CFR 1308.11(d)(73)
methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F-AMB)Schedule IHallucinogenic substances703321 CFR 1308.11(d)(74)
methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (other names: 5F-MDMB-PICA; 5F-MDMB-2201)Schedule IHallucinogenic substances704121 CFR 1308.11(d)(90)
methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB-CHMICA, MMB-CHMINACA)Schedule IHallucinogenic substances704221 CFR 1308.11(d)(77)
methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA)Schedule IHallucinogenic substances704421 CFR 1308.11(d)(84)
methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA)Schedule IHallucinogenic substances709021 CFR 1308.11(d)(110)
Methyl (E)-2-((1′S,6′S,7′S)-6′-ethyl-4-methoxy-3-oxo-3′,5′,6′,7′,8′,8a′-hexahydro-2′H-spiro[indoline-2,1′-indolizine]-7′-yl)-3-methoxyacrylate (commonly known as mitragynine pseudoindoxyl) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are coveredSchedule ITemporary listing of substances subject to emergency scheduling9672Aug. 26, 202821 CFR 1308.11(h)(89)
Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-15; also known as dihydro-7-hydroxymitragynine) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are coveredSchedule ITemporary listing of substances subject to emergency scheduling9673Aug. 26, 202821 CFR 1308.11(h)(90)
Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a-hydroxy-8- methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (commonly known as MGM-16; also known as 9-fluoro-dihydro-7-hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine (depending on numbering convention)) including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible. Since nomenclature of this substance is not internationally standardized, compounds of this structure, regardless of numerical designation of atomic positions are coveredSchedule ITemporary listing of substances subject to emergency scheduling9674Aug. 26, 202821 CFR 1308.11(h)(91)
MethyldesorphineSchedule IOpium derivatives930221 CFR 1308.11(c)(13)
methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(59)
MethyldihydromorphineSchedule IOpium derivatives930421 CFR 1308.11(c)(14)
MethylphenidateSchedule IIStimulants172421 CFR 1308.12(d)(4)
Methylphenobarbital (mephobarbital)Schedule IVDepressants225021 CFR 1308.14(c)(40)
methyltestosterone (17α-methyl-17β-hydroxyandrost-4-en-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(61)
methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11-trien-3-one)Schedule IIIAnabolic steroids21 CFR 1308.13(f)(62)
MethyprylonSchedule IIIDepressants257521 CFR 1308.13(c)(10)
Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)Schedule IOpiates976421 CFR 1308.11(b)(67)

Showing the first 400 of 591 records. Every record has its own page, with its source and the quoted line that states it; these list the rest.

Where this came from

Every record above links the page it was taken from and quotes the sentence that states it. These are the 1 source this dataset was assembled from.

Machine-readable

From your own code

Same records, same quotes, without scraping the page: refsource is on PyPI and npm. Each value comes back carrying the URL it was read from and the sentence on that page that states it — .source and .quote sit on the value itself rather than in a side channel, so the checking step is available instead of skipped.

pip install refsource
refsource lookup dea-controlled-substance-schedule-by-drug schedule="Schedule I"

npx -y refsource lookup dea-controlled-substance-schedule-by-drug schedule="Schedule I"

591 records. last verified against source . due for re-check by .

Licence. Federal regulatory text (21 CFR), not copyrightable